2 active trials 1 recruiting 3 disease areas
| First posted | New trial filing | Phase | Status |
|---|---|---|---|
| 2026-08-27 | NCT07789444 Sacituzumab Tirumotecan（Sac-TMT） and Brain Radotherapy for EGFR+ NSCLC With Brain Mets | Phase 2 | Not Yet Recruiting |
| Phase 2 | 2 |
| NCT ID | Title | Condition | Status | Updated |
|---|---|---|---|---|
| Phase 2 | ||||
| NCT05745350 | First Line Pembrolizumab, Plinabulin Plus Etoposide and Platinum (EP) for ES-SCLC | Small Cell Lung Cancer Extensive Stage | Recruiting | 2025-02-11 |
| NCT07789444 | Sacituzumab Tirumotecan（Sac-TMT） and Brain Radotherapy for EGFR+ NSCLC With Brain Mets | Non-Small Cell Lung Cancer | Not Yet Recruiting | 2026-08-27 |
Lung Cancer (2) · Non-Small Cell Lung Cancer (NSCLC) (1) · Small Cell Lung Cancer (1)